Breathe Well Live Well
|
Research and Markets: United States Asthma Drugs Market 2015-2019 …
Yahoo Finance UK The report, Asthma Drugs Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report also includes … |
View full post on asthma – Google News
Yahoo News |
Cesarean birth may raise baby's risk of asthma, diabetes and obesity
Yahoo News (Reuters Health) – While cesarean deliveries are often necessary to save lives and prevent injuries, being born by C-section may also leave babies vulnerable to chronic health problems such as asthma, diabetes and obesity, a new analysis suggests. Much … C-sections may increase baby's risk of asthma, diabetes, obesity C-section births linked to long-term child health problems C-Section Babies Could Face Chronic Health Problems of Asthma, Diabetes … |
View full post on asthma – Google News
euronews |
AstraZeneca's patent on asthma drug invalidated by US court
Yahoo News NEW YORK (Reuters) – A U.S. federal judge ruled late on Friday that AstraZeneca PLC's patent on its Pulmicort Repsules treatment for asthma was invalid, opening up the market to a second, cheaper generic version. Actavis Plc said that the U.S. District … Actavis launches Pulmicort Respules generic on AZ legal loss |
View full post on asthma – Google News
Yahoo News |
Million asthma sufferers may be misdiagnosed: UK watchdog
Yahoo News Around 4.1 million people in Britain receive treatment for asthma but studies suggest that up to 30 percent do not show clear evidence of having the illness, the National Institute for Health and Care Excellence (NICE) said. Some may have had asthma in … One million asthma sufferers may not have the condition, warns health watchdog Over 1m people with asthma may NOT have the condition and could be taking … More than 1m people in UK may have been wrongly diagnosed with asthma |
View full post on asthma – Google News
Yahoo News |
Big city life may not be a key asthma risk: US study
Yahoo News CHICAGO (Reuters) – The simple fact of growing up in a big city may not be a major factor in whether a child develops asthma, according to a new study that contradicts decades of public health assumptions about the so-called inner city asthma epidemic. |
View full post on asthma – Google News
Yahoo News |
US study finds inner city doesn't raise asthma risk
Yahoo News Instead, it found that being poor, African-American or Puerto Rican were more significant risk factors for asthma than urban living, said the findings by researchers at the John Hopkins University. The study published in the Journal of Allergy and … |
View full post on asthma – Google News
|
Winter sees spurt in asthma symptoms in UAE
Yahoo! Maktoob News As the Middle East witnesses one of its worst winter storms in decades this month, asthma sufferers throughout the UAE may find themselves reaching for their inhalers more often than usual. As if airborne dust from the continued construction works and … |
View full post on asthma – Google News
|
Britain's Vectura collaborates with Janssen in asthma, COPD
Yahoo News LONDON (Reuters) – Vectura Group, a respiratory drugs specialist, will work with Janssen Biotech to develop treatments for asthma and lung disease COPD, it said on Tuesday. The collaboration will kick off with the development of a drug candidate for … Vectura Signs Global Development And Licence Deal With Janssen In Asthma … Vectura links with Janssen on asthma/COPD drug development J&J and Vectura sign asthma/COPD deal |
View full post on asthma – Google News
Yahoo News UK |
Cleaning device may aid asthmatics
Yahoo News UK Professor Peter Howarth, a specialist in asthma and allergy at Southampton General Hospital, said: "While the majority of asthmatics are able to control their symptoms with medication, around one in 10 regularly experiences life-threatening symptoms … |
View full post on asthma – Google News
|
Dynavax & AstraZeneca Alter Agreement for Asthma Product
Yahoo News As per the agreement, AstraZeneca will now provide full funding while Dynavax will conduct a phase IIa safety and efficacy trial on pipeline candidate AZD1419 in asthma patients. Dynavax plans to initiate the study in the first half of 2015. The … |
View full post on asthma – Google News